These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Antiepileptic drugs in North America]. Akiyama T; Otsubo H Brain Nerve; 2010 May; 62(5):519-26. PubMed ID: 20450099 [TBL] [Abstract][Full Text] [Related]
7. New antiepileptic drugs that are second generation to existing antiepileptic drugs. Bialer M Expert Opin Investig Drugs; 2006 Jun; 15(6):637-47. PubMed ID: 16732716 [TBL] [Abstract][Full Text] [Related]
9. Novel medications for epilepsy. Fattore C; Perucca E Drugs; 2011 Nov; 71(16):2151-78. PubMed ID: 22035515 [TBL] [Abstract][Full Text] [Related]
10. Newer anti-epileptic drugs. Aneja S; Sharma S Indian Pediatr; 2013 Nov; 50(11):1033-40. PubMed ID: 24382900 [TBL] [Abstract][Full Text] [Related]
11. An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Jacob S; Nair AB Drugs R D; 2016 Dec; 16(4):303-316. PubMed ID: 27766590 [TBL] [Abstract][Full Text] [Related]
12. Recent and future antiepileptic drugs and their impact on cognition: what can we expect? Mula M Expert Rev Neurother; 2012 Jun; 12(6):667-71. PubMed ID: 22650169 [TBL] [Abstract][Full Text] [Related]
13. Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs. Patsalos PN Clin Pharmacokinet; 2013 Nov; 52(11):927-66. PubMed ID: 23784470 [TBL] [Abstract][Full Text] [Related]
14. Chemical properties of antiepileptic drugs (AEDs). Bialer M Adv Drug Deliv Rev; 2012 Jul; 64(10):887-95. PubMed ID: 22210279 [TBL] [Abstract][Full Text] [Related]
15. Drug interactions involving the new second- and third-generation antiepileptic drugs. Johannessen Landmark C; Patsalos PN Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326 [TBL] [Abstract][Full Text] [Related]
16. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952 [TBL] [Abstract][Full Text] [Related]
17. Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Bialer M; Johannessen SI; Kupferberg HJ; Levy RH; Perucca E; Tomson T Epilepsy Res; 2007 Jan; 73(1):1-52. PubMed ID: 17158031 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate. Patsalos PN; Berry DJ Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663 [TBL] [Abstract][Full Text] [Related]
19. Rufinamide for the treatment of Lennox-Gastaut syndrome: evidence from clinical trials and clinical practice. Striano P; McMurray R; Santamarina E; Falip M Epileptic Disord; 2018 Feb; 20(1):13-29. PubMed ID: 29313492 [TBL] [Abstract][Full Text] [Related]